Skip to main content

Hemodynamic Instability

0
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Eppendorf
EppendorfGermany - Hamburg
1 program
Individualized Goal Directed TherapyN/A1 trial
Active Trials
NCT03021525Completed380Est. Aug 2023
Medtronic
MedtronicNJ - Phillipsburg
1 program
Initial bolus pre-incisionN/A1 trial
Active Trials
NCT02365688Terminated18Est. Jun 2015
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
caffeine intakeN/A1 trial
Active Trials
NCT02544165Completed178Est. Jun 2014
Nihon Kohden
Nihon KohdenNEW YORK, NY
1 program
estimated stroke volume variationN/A1 trial
Active Trials
NCT04786652Completed32Est. Dec 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Nihon Kohdenestimated stroke volume variation
EppendorfIndividualized Goal Directed Therapy
MedtronicInitial bolus pre-incision
UNION therapeuticscaffeine intake

Clinical Trials (4)

Total enrollment: 608 patients across 4 trials

NCT04786652Nihon Kohdenestimated stroke volume variation

Fluid Responsiveness: SVV vs esSVV in Mechanically Ventilated and Spontaneously Breathing Patients

Start: Mar 2021Est. completion: Dec 202132 patients
N/ACompleted
NCT03021525EppendorfIndividualized Goal Directed Therapy

Individualized Perioperative Hemodynamic Goal-directed Therapy in Major Abdominal Surgery (iPEGASUS-trial)

Start: Aug 2017Est. completion: Aug 2023380 patients
N/ACompleted
NCT02365688MedtronicInitial bolus pre-incision

Hemodynamic Response During Goal Directed Fluid Therapy in the OR

Start: Sep 2014Est. completion: Jun 201518 patients
N/ATerminated
NCT02544165UNION therapeuticscaffeine intake

Non Invasive Measurement of the Haemodynamic Parameters and of the Advanced Glycation End Products (AGEs) Levels

Start: Nov 2012Est. completion: Jun 2014178 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.